Clinical Trial

Tumor-Derived FGF19

Completed
View on ClinicalTrials.gov →
Summary
Identify and test thresholds, specificity and sensitivity for a potential cancer associated biomarker protein, FGF19, (and associated markers) for detection in human blood in the blood of breast and colorectal in cancer patients, and see if occurs at higher rates than healthy controls
Protocol Amendment History 4 changes
critical Trial completed 2026-07-31
notable Enrollment reduced: 210 -> 119 participants 2026-07-31
notable Primary completion pushed: 2025-06 -> 2026-06-04 2026-07-31
minor Completion pushed: 2025-06 -> 2026-07-01 2026-07-31
Trial Details
NCT Number NCT06068257
Lead Sponsor University of Central Florida
Conditions Colorectal Cancer, Breast Cancer, Healthy
Enrollment 119 participants
Start Date 2023-06-06
Primary Completion 2026-06-04 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-30